Skip to content
Moojaz — موجز
Search
Menu
HomeRegionsMaghrebAfricaMiddle EastEuropeAsiaAmericasWorldSectionsPoliticsEconomySecurityHealthScienceTechnologyAIEnvironmentCultureSportsSearch
France
File

France: medical laboratory funding and public-health roles

This dossier follows medical laboratory funding agreements and changes to their public-health roles.

Last updated : 1 key moments
Two test tubes in a rack.
Archive illustration from April 2006; does not show a laboratory covered by the pact. Jeffrey M. Vinocur, CC BY 2.5. — Jeffrey M. Vinocur / Wikimedia Commons — CC BY 2.5 https://creativecommons.org/licenses/by/2.5/ — 21 avril 2006, sans modification.

Where things stand

On 2 November 2026, French health insurance announced a 2027–2029 protocol signed with Unocam and four unions. It provides 1.1% annual growth in the routine-test funding envelope.

Reported information

French laboratory pact sets 2027–2029 spending path and €100 million for innovation

French health insurance, Unocam and four laboratory unions signed a 2027–2029 protocol on 2 November 2026, the public insurer said. Routine-test funding is to grow 1.1% annually, with €100 million over three years allocated to new procedures.

Two test tubes in a rack.
Archive illustration from April 2006; does not show a laboratory covered by the pact. Jeffrey M. Vinocur, CC BY 2.5. — Jeffrey M. Vinocur / Wikimedia Commons — CC BY 2.5 https://creativecommons.org/licenses/by/2.5/ — 21 avril 2006, sans modification.

Funding for new procedures will be separate from the mechanism regulating routine tests. A committee will monitor spending and may propose fee adjustments to keep within the agreed envelopes.

The protocol also envisages a stronger role in prevention and chronic-disease monitoring. Further negotiations on the professional agreement are to follow. Proposed changes to professional powers still need to be reflected in the applicable texts: the pact alone does not allow every procedure to be performed without a prescription.

Sources 3